High-resolution of comparative genomic hybridization improves
detection of chromosomal aberrations with prognostic
significance  in neuroblastoma

D 2006

High-resolution of comparative genomic hybridization improves detection of chromosomal aberrations with prognostic significance in neuroblastoma

KUGLÍK, Petr, Vladimíra VRANOVÁ, Dita ŽEŽULKOVÁ, Lenka ŠTEFANČÍKOVÁ, Eva NEČESALOVÁ et. al.

Basic information

Original name

High-resolution of comparative genomic hybridization improves detection of chromosomal aberrations with prognostic significance in neuroblastoma

Name in Czech

Použití techniky komparativní genomové hybridizace s vysokým rozlišením (HR-CGH) zlepšuje detekci chromozomových aberací s prognostickým významem u neuroblastomu

Authors

KUGLÍK, Petr (203 Czech Republic, guarantor), Vladimíra VRANOVÁ (703 Slovakia), Dita ŽEŽULKOVÁ (203 Czech Republic), Lenka ŠTEFANČÍKOVÁ (203 Czech Republic), Eva NEČESALOVÁ (203 Czech Republic), Hana FILKOVÁ (203 Czech Republic), Alexandra OLTOVÁ (203 Czech Republic), Pavel MAZÁNEK (203 Czech Republic) and Jaroslav ŠTĚRBA (203 Czech Republic)

Edition

Amsterdam, Europen Journal of Human Genetics, p. 184-184, 2006

Publisher

ESHG

Other information

Language

English

Type of outcome

Stať ve sborníku

Field of Study

Genetics and molecular biology

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 3.697

RIV identification code

RIV/00216224:14310/06:00017834

Organization unit

Faculty of Science

ISSN

Keywords in English

neuroblastoma; high resolution comparative genomic hybridization; chromosomal aberration; prognostic factors

Abstract

ORIG CZ

V originále

Neuroblastoma (NB) is a genetically very heterogeneous pediatric malignant tumor. The clinical course of NB vary markedly. Therefore molecular and cytogenetic markers are studied as strong predictors of clinical outcome, to amnedclinical staging and aid in treatment planning. This malignancy is characterized by a broad spectrum of clinical behavior. Low-, intermediate, and high-risk groups have been defined based upon expected outcome following conventional therapy using both clinical and biological criteria. The criteria currently used to assign risk-group are as follows: Clinical stage, MYCN status, Shimada histology and DNA ploidy. Recently, other cytogenetic changes as 1p, 3p, 11q deletions and 17q rearrangements may also have prognostic value. The are a number of molecular genetic features known which are of prognostic importance in neuroblastoma - expression of different molecular markers as neurotrophin tyrosin kinase receptors (TrkA, B and C), tyrosine hydroxylase, neuroendocrine protein gene product 9,5 (PGP9,5), telomerase reverse transcriptase (hTERT) and vascular endothelial growth factor-A (VEGF-A). Some of them are already candidates stratifying markers. A global view of cytogenetic imbalances in NB patients can be detected by CGH. With recently developed high resolution (HR-CGH) method, we can find aberrations of < 10 Mb. In this study we report about the application of FISH and CGH/HR-CGH method for the detection of chromosomal imbalances in NB patients. In our work, FISH technique and CGH analyses were applied to 49 neuroblastomas of both low and high stage disease and the data were reviewed and correlated with clinical characteristics, including survival analysis.

In Czech

Práce se zabývá využitím techniky komparativní genomé hybridizace s vysokým rozlišením (HR-CGH) při vyšetření cytogenetických změn s prognostickým významem u pacientů s neuroblastomem léčených na KDO FN Brno.

Links

MSM0021622415, plan (intention)

Name: Molekulární podstata buněčných a tkáňových regulací

Investor: Ministry of Education, Youth and Sports of the CR, Molecular basis of cell and tissue regulations

NR9125, research and development project

Name: Diagnostický a prediktivní význam molekulárně cytogenetických markerů u embryonálních nádorů dětského věku.

Investor: Ministry of Health of the CR

Citovat

KUGLÍK, Petr, Vladimíra VRANOVÁ, Dita ŽEŽULKOVÁ, Lenka ŠTEFANČÍKOVÁ, Eva NEČESALOVÁ, Hana FILKOVÁ, Alexandra OLTOVÁ, Pavel MAZÁNEK and Jaroslav ŠTĚRBA. High-resolution of comparative genomic hybridization improves detection of chromosomal aberrations with prognostic significance in neuroblastoma. In Europen Journal of Human Genetics. Amsterdam: ESHG, 2006, p. 184. ISSN 1018-4813.

@inproceedings{705150,
   author = {Kuglík, Petr and Vranová, Vladimíra and Žežulková, Dita and Štefančíková, Lenka and Nečesalová, Eva and Filková, Hana and Oltová, Alexandra and Mazánek, Pavel and Štěrba, Jaroslav},
   address = {Amsterdam},
   booktitle = {Europen Journal of Human Genetics},
   keywords = {neuroblastoma; high resolution comparative genomic hybridization; chromosomal aberration; prognostic factors},
   language = {eng},
   location = {Amsterdam},
   pages = {184-184},
   publisher = {ESHG},
   title = {High-resolution of comparative genomic hybridization improves detection of chromosomal aberrations with prognostic significance in neuroblastoma},
   year = {2006}
}

TY  - JOUR
ID  - 705150
AU  - Kuglík, Petr - Vranová, Vladimíra - Žežulková, Dita - Štefančíková, Lenka - Nečesalová, Eva - Filková, Hana - Oltová, Alexandra - Mazánek, Pavel - Štěrba, Jaroslav
PY  - 2006
TI  - High-resolution of comparative genomic hybridization improves detection of chromosomal aberrations with prognostic significance in neuroblastoma
PB  - ESHG
CY  - Amsterdam
KW  - neuroblastoma
KW  - high resolution comparative genomic hybridization
KW  - chromosomal aberration
KW  - prognostic factors
N2  - Neuroblastoma (NB) is a genetically very heterogeneous pediatric malignant tumor. The clinical course of NB vary markedly. Therefore molecular and cytogenetic markers are studied as strong predictors of clinical outcome, to amnedclinical staging and aid in treatment planning. This malignancy is characterized by a broad spectrum of clinical behavior. Low-, intermediate, and high-risk groups have been defined based upon expected outcome following conventional therapy using both clinical and biological criteria. The criteria currently used to assign risk-group are as follows: Clinical stage, MYCN status, Shimada histology and DNA ploidy. Recently, other cytogenetic changes as 1p, 3p, 11q deletions and 17q rearrangements may also have prognostic value. The are a number of molecular genetic features known which are of prognostic importance in neuroblastoma - expression of different molecular markers as neurotrophin tyrosin kinase receptors (TrkA, B and C), tyrosine hydroxylase, neuroendocrine protein gene product 9,5 (PGP9,5), telomerase reverse transcriptase (hTERT) and vascular endothelial growth factor-A (VEGF-A). Some of them are already candidates stratifying markers. A global view of cytogenetic imbalances in NB patients can be detected by CGH. With recently developed high resolution (HR-CGH) method, we can find aberrations of < 10 Mb. In this study we report about the application of FISH and CGH/HR-CGH method for the detection of chromosomal imbalances in NB patients. In our work, FISH technique and CGH analyses were applied to 49 neuroblastomas of both low and high stage disease and the data were reviewed and correlated with clinical characteristics, including survival analysis.
ER  -

KUGLÍK, Petr, Vladimíra VRANOVÁ, Dita ŽEŽULKOVÁ, Lenka ŠTEFANČÍKOVÁ, Eva NEČESALOVÁ, Hana FILKOVÁ, Alexandra OLTOVÁ, Pavel MAZÁNEK and Jaroslav ŠTĚRBA. High-resolution of comparative genomic hybridization improves detection of chromosomal aberrations with prognostic significance in neuroblastoma. In \textit{Europen Journal of Human Genetics}. Amsterdam: ESHG, 2006, p.~184. ISSN~1018-4813.

Detailed Information on Publication Record